Press Releases April 15, 2026 08:00 PM

SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.

SRx Health Solutions Advances EMJ Crypto Technologies Merger and Expands Equity Investments

By Jordan Park SRXH
SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.
SRXH

SRx Health Solutions, Inc. (NYSE American: SRXH) announced the filing of Form S-4 with the SEC related to its merger agreement with EMJ Crypto Technologies (EMJX). The company also reported acquiring shares of Compass Inc. and increasing its investment in Opendoor Technologies Inc. Additionally, SRx Health noted strong recent performance with gains in its hedging pool and long treasury holdings and plans to provide quarterly updates on market performance metrics.

Key Points

  • SRx Health Solutions filed a Form S-4 with the SEC in connection with its proposed merger with EMJ Crypto Technologies.
  • The company has acquired shares of Compass Inc. and increased its investment in Opendoor Technologies Inc., expanding its equity portfolio.
  • Reported a 3.5% gain in its hedging pool driven by EMJX’s algorithm and an 8% gain in its long treasury investments through mid-April.

SRXH files Form S-4 with SEC in connection with EMJX merger 

SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX’s algorithm, and an approximate gain of 8% in its long treasury investment holdings

NORTH PALM BEACH, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring shares in the open market of Compass Inc. and increasing its investment in Opendoor Technologies Inc. Further to additions to its portfolio, the Company is pleased to report that it has filed a Form S-4 with the Securities and Exchange Commission in connection with its proposed merger with EMJX. The full filing can be found at https://s3.amazonaws.com/sec.irpass.cc/2454/0001493152-26-016588.htm.

Michael Young, Director of SRx Health, said, “We are excited to further the EMJX acquisition along and look forward to welcoming Eric and his team. While we are excited and encouraged by our initial reported hedging pool and treasury investment performance, going forward, we will provide market performance metrics on a quarterly basis.”

Additional Information and Where to Find It
In connection with the proposed transaction between the Company and EMJX, the Company has filed with the SEC a Registration Statement on Form S-4 (the "Registration Statement") to register the common stock to be issued in connection with the proposed transaction. The Registration Statement includes an information statement of the Company and a prospectus of the Company (the "Information Statement/Prospectus"). Each of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders. This is not a substitute for the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENTAND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus, as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available, at the SEC's website at www.sec.gov. The information on EMJX's or the Company's respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.

No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
[email protected]


Risks

  • Completion of the proposed merger depends on shareholder approvals and regulatory considerations which may introduce uncertainty.
  • Market conditions could adversely affect ongoing performance and future valuations of investments such as Compass Inc. and Opendoor Technologies.
  • Forward-looking statements indicate risks related to changing market environments and possible delays or failure to consummate the merger impacting shareholder value.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026